Invectys at the Third International Symposium on Immunotherapy organised by The Institute for Cancer Vaccines & Immunotherapy (previously known as the Cancer Vaccine Institute).
The 3rd International Symposium on Immunotherapy will be held at the prestigious Royal Society in London, on 12th & 13th May 2017.
Invectys will present an abstract about “Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response”.
